Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer

  1. Calvo, R.
  2. Jiménez, R.Ma.
  3. Trocóniz, I.F.
  4. Suárez, E.
  5. Gonzalo, A.
  6. Lucero, Ma.L.
  7. Raczka, E.
  8. Orjales, A.
Revue:
Cancer Chemotherapy and Pharmacology

ISSN: 0344-5704

Année de publication: 1998

Volumen: 42

Número: 5

Pages: 418-422

Type: Article

DOI: 10.1007/S002800050839 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus